Literature DB >> 18758966

Hydroxypropyl methylcellulose acetate succinate: potential drug-excipient incompatibility.

Zedong Dong1, Duk Soon Choi.   

Abstract

The stability of hydroxypropyl methylcellulose acetate succinate (HPMC-AS) and its potential incompatibility with active pharmaceutical ingredients (API) carrying hydroxyl group(s) were investigated in this research. HPMC-AS may undergo hydrolysis under harsh processing conditions with the generation of succinic acid and acetic acid, which can form ester bond(s) with the hydroxyl group(s) in API. In this case, the hot-melt extrusion (HME) product prepared from HPMC-AS and our model compound (compound A) was tested after heating at 140 degrees C up to 5 h. The succinate esters of compound A and its epimer were found in the product, suggesting potential drug-excipient incompatibility during formulation development. In addition, dyphylline was also tested with HPMC-AS and the potential incompatibility was further confirmed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758966      PMCID: PMC2977018          DOI: 10.1208/s12249-008-9138-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  9 in total

Review 1.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

Authors:  A T Serajuddin
Journal:  J Pharm Sci       Date:  1999-10       Impact factor: 3.534

2.  Selection of solid dosage form composition through drug-excipient compatibility testing.

Authors:  A T Serajuddin; A B Thakur; R N Ghoshal; M G Fakes; S A Ranadive; K R Morris; S A Varia
Journal:  J Pharm Sci       Date:  1999-07       Impact factor: 3.534

3.  A new approach to accelerated drug-excipient compatibility testing.

Authors:  Jonathan L Sims; Judith A Carreira; Daniel J Carrier; Simon R Crabtree; Lynne Easton; Stephen A Hancock; Carol E Simcox
Journal:  Pharm Dev Technol       Date:  2003       Impact factor: 3.133

4.  Drug-excipient compatibility testing using a high-throughput approach and statistical design.

Authors:  Nicole Wyttenbach; Christian Birringer; Jochem Alsenz; Martin Kuentz
Journal:  Pharm Dev Technol       Date:  2005       Impact factor: 3.133

5.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

6.  Compatibility of sennoside A and B with pharmaceutical excipients.

Authors:  Q Verloop; A F Marais; M M de Villiers; W Liebenberg
Journal:  Pharmazie       Date:  2004-09       Impact factor: 1.267

7.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

8.  Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.

Authors:  Fumié Tanno; Yuichi Nishiyama; Hiroyasu Kokubo; Sakaé Obara
Journal:  Drug Dev Ind Pharm       Date:  2004-01       Impact factor: 3.225

9.  Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation.

Authors:  Zedong Dong; Ashish Chatterji; Harpreet Sandhu; Duk Soon Choi; Hitesh Chokshi; Navnit Shah
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

  9 in total
  6 in total

Review 1.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

Review 2.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

Review 3.  Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.

Authors:  Arun Butreddy; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2020-11-28       Impact factor: 4.384

4.  Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.

Authors:  Deck Khong Tan; Daniel A Davis; Dave A Miller; Robert O Williams; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2020-11-08       Impact factor: 3.246

5.  Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity.

Authors:  Daniel A Davis; Dave A Miller; Supawan Santitewagun; J Axel Zeitler; Yongchao Su; Robert O Williams
Journal:  Int J Pharm X       Date:  2021-07-17

6.  Processing of Polyvinyl Acetate Phthalate in Hot-Melt Extrusion-Preparation of Amorphous Solid Dispersions.

Authors:  Marius Monschke; Kevin Kayser; Karl G Wagner
Journal:  Pharmaceutics       Date:  2020-04-09       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.